The Madras High Court clarified the interpretation of Section 3(c) in the context of monoclonal antibodies patent in Genmab A/S v. Assistant Controller of Patents. The court emphasized the importance of novelty and technical advancement for patent eligibility. Continue Reading Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)
The Calcutta High Court’s landmark decision in Vodafone v. Saregama clarifies the royalty rights of authors of literary and musical works. The ruling states that authors are entitled to royalties regardless of when their works were created or the nature of copyright ownership transfers. Continue Reading Authors, Copyright and Royalty Share : The Calcutta High Court gives clarity
Indi Pharma Pvt Ltd successfully petitioned the High Court of Bombay to restore its trademark application for VOMISET and allow its renewal. The Court’s decision was based on the precedent set in the Motwane case, highlighting the importance of proper notification for trademark renewals. Continue Reading All set for VOMISET : Court restores trademark and allows renewal beyond deadline
The Madras High Court criticized the Patent Office for using outdated CRI guidelines of 2016 instead of the revised 2017 guidelines in evaluating Microsoft’s patent application. The court emphasized the importance of assessing technical effect or contribution in CRIs without considering hardware. Continue Reading Court criticizes Patent Office for using outdated CRI Guidelines
The WIPO Treaty on Intellectual Property, Genetic Resources, and Traditional Knowledge aims to enhance patent system efficiency and transparency regarding genetic resources and traditional knowledge. Continue Reading Note on the WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge
The Madras High Court, in a decision dated March 19, 2024, set aside a patent refusal order issued by the Assistant Controller of Patents and Designs in the case of a patent application filed by Novozymes A/S. This post summarizes the decision of the court in this case. Continue Reading Victory for Novozymes: Madras High Court Overrules Patent Office’s Refusal
The Delhi High Court ruled in favor of Anuj Bindal, the prior user of ‘Dabal Kabooter Brand,’ in a trademark dispute against ‘Double Kabooter Brand.’ This case highlights the importance of prior use and the implications of false statements in trademark applications. Continue Reading Court says infringing brand ‘Double Kabooter’ Jaa Jaa Jaa
Delhi High Court upholds Haldiram’s trademark rights, awarding Rs. 50 lakhs in damages and recognizing ‘HALDIRAM’ as a well-known mark in a legal battle against unauthorized use. Continue Reading Snack Wars: Haldiram’s Battle for Brand Supremacy
Delhi High Court revives Dabur’s ODONIL MYSTIC ROSE trademark application, citing procedural lapses by the Trade Marks Registry in serving the notice of opposition. Continue Reading Lost in the Inbox? Delhi High Court Saves Dabur’s Trademark Application
In a landmark decision, the Delhi High Court overturned an injunction against Natco, allowing them to produce a generic version of Novartis’s cancer drug. The Court held that Novartis’s patent on a specific salt form of the drug (ELT-O) lacked novelty due to its coverage in an earlier patent (IN’176). Continue Reading Cancerous Battle: Novartis and NATCO clash over Eltrombopag